Sonoma Pharmaceuticals(us:SNOA)

2.19

-9.13%

Updated on 2025-03-31

Open:2.34
Close:2.19
High:2.40
Low:2.12
Prev Close:2.41
Volume:138750.00
Turnover:315236.41
Turnover Ratio:8.59%
Shares:1.62M
MarketCap:3.54M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30224349992.29%655
2024-03-31211642731.05%427
2023-12-31203037782.22%715
2023-09-30161258162.43%027
2023-06-30211619473.15%218
2023-03-31201467172.97%534
2022-12-31191426834.59%217
2022-09-30181791135.77%026
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Susquehanna International Group, Llp460520.30%46052
2024-03-31Geode Capital Management, Llc357800.23%0
2024-03-31State Street Corp243150.16%0
2024-03-31Xtx Topco Ltd164630.11%16463
2024-03-31Two Sigma Securities, Llc134730.09%13473
2024-03-31Millennium Management Llc130160.08%-18881-59.19%
2024-03-31Tower Research Capital Llc (Trc)119800.08%246225.87%
2024-03-31Blackrock Inc.22660.01%0
2024-03-31Us Bancorp \De\5000.00%0
2024-03-31Wells Fargo & Company/Mn1220.00%1716.19%

About

Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Address:5445 Conestoga Court,Suite 150

Market Movers